Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C000655704
http://purl.bioontology.org/ontology/MESH/C000655704
|
|---|---|
| Preferred Name | pralsetinib |
| Synonyms |
Cyclohexanecarboxamide, N-((1S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)-, trans-
BLU-667
trans-N-((1S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)cyclohexanecarboxamide
gavreto
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel | Cyclohexanecarboxamide, N-((1S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)-, trans-
BLU-667
trans-N-((1S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)cyclohexanecarboxamide
gavreto
|
|---|---|
| prefLabel | pralsetinib
|
| Scope Statement | RET inhibitor
|
| type | |
| isa | |
| PA | D000970
|
| tui |
T109
T121
|
| HM |
D011743
D011725
D011720
|
| SC | 1
|
| TERMUI |
T001001596
T001001536
T001001576
T001109019
T001001537
|
| TH |
NLM (2020)
NLM (2021)
|
| SRC | Cancer Discov. 2018 Jul;8(7):836-849.
|
| MMR | 20210721
|
| notation | C000655704
|
| Semantic type UMLS property | |
| cui |
C5226874
C4331210
C5226245
C5401922
|
| MeSH Frequency | 48
|
| LT | TRD
|
| DSC | 20191216
|
| Inverse of RB | 0
|
| Mapped to | |
| MDA | 20191216
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |